Health TrialsbyHealthPanel

Short Implant Versus Crestal Standard Length Implant to Retain Class 1 Removable Partial Denture.

ConditionsBone LossPartial Edentulism Class 1
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-70
SponsorMenoufia University

About this trial

Objective: To report the implant survival rates, clinical, and radiographic outcomes of subcrestal short implant versus crestal standard length implant supported removable partial denture (RPD).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

adult patients aged 50 years or older with class 1 RPD with missing mandibular molars at least and complaining from instability of the prosthesis were recruited.

Medical history revealed no contraindication to implant therapy.

Patients have an amount of bone nearly equal to 8 mm length above the inferior alveolar canal to receive a 6 mm short implant with 2 mm subcrestal to the bone level with sufficient bone width ≥ 8mm on one side and an amount of bone equal to or more than 8 mm to receive a standard-length implant of 7.5, 9, or 10.5 mm placed at crestal bone level with sufficient bone width ≥ 8mm on the contralateral side which was examined by CBCT.

Disqualifiers

Presence of active infection or inflammation in the areas intended for implant placement; *systemic diseases such as diabetes.

Pregnant and lactating patients.

Habit of severe bruxism or clenching.

Treatment with therapeutic radiation to the head within the past 12 months.

Trial design

Design model

Sequential

Treatments tested in this trial

  • Titanium dental implant (Conical SPI, Vitronix, Italy), Medical device that interfaces with the jawbone to support a dental prosthesis.

    Procedure/Surgery

    Placement of titanium dental implant to retain and support Kennedy class 1 removable partial denture (RPD).The implant fuses with the bone through a process called osseointegration.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Subcrestal short implantActive comparator 1 intervention
Group B: crestal standard length implantActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Bone loss

Evaluation of crestal bone loss around implants will be performed by periapical digital radiograph using parallel technique to avoid distortion or elongation to the image.

Time frame
3 years

Secondary outcomes

1

Plaque index (PI)

Evaluation of PI around implants were assessed by using a numerical recording of BI (present = 1; absent = 0), PI (present = 1; absent = 0), as well as PD. With the use of a plastic periodontal probe (Hu-Friedy, Chicago, Illinois).

Time frame
3 years
2

Bleeding on probing (BOP)

Evaluation of BOP around implants were assessed by using a numerical recording of BOP (present = 1; absent = 0), PI (present = 1; absent = 0), as well as PD. With the use of a plastic periodontal probe (Hu-Friedy, Chicago, Illinois).

Time frame
3 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Menoufia University

Lead sponsor

Tanta University

Collaborator

Source ClinicalTrials.gov
Apply now